These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22397669)

  • 61. HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report.
    Boidot R; Chevrier S; Julie V; Ladoire S; Ghiringhelli F
    Int J Colorectal Dis; 2016 Jun; 31(6):1245-6. PubMed ID: 26561417
    [No Abstract]   [Full Text] [Related]  

  • 62. Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.
    Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
    Drug Resist Updat; 2011 Dec; 14(6):280-96. PubMed ID: 21955833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancer.
    Eng C
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):174-5. PubMed ID: 18391915
    [No Abstract]   [Full Text] [Related]  

  • 64. SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway.
    Guan H; Zhao P; Dai Z; Liu X; Wang X
    Tumour Biol; 2016 Sep; 37(9):12153-12160. PubMed ID: 27220321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.
    Chouhan S; Singh S; Athavale D; Ramteke P; Pandey V; Joseph J; Mohan R; Shetty PK; Bhat MK
    Sci Rep; 2016 Jun; 6():27558. PubMed ID: 27272409
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Mutation of HSP110 in colorectal cancer: the chaperone paradox].
    Garrido C; Collura A; Berthenet K; Lagrange A; Duval A
    Med Sci (Paris); 2012 Jan; 28(1):9-10. PubMed ID: 22289816
    [No Abstract]   [Full Text] [Related]  

  • 69. Tumor heterogeneity and response to chemotherapy.
    Sugino S; Janicki PK
    Pharmacogenomics; 2013 Dec; 14(16):1949. PubMed ID: 24279849
    [No Abstract]   [Full Text] [Related]  

  • 70. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
    Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
    Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beyond KRAS: a new approach in metastatic colorectal cancer.
    Winder T; Lenz HJ
    Lancet Oncol; 2010 Aug; 11(8):706-7. PubMed ID: 20619738
    [No Abstract]   [Full Text] [Related]  

  • 72. Accurate Measurement of DNA Methylation: Challenges and Bias Correction.
    Ochoa E; Zuber V; Bottolo L
    Methods Mol Biol; 2022; 2432():25-47. PubMed ID: 35505205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A literature review on function and regulation mechanism of DKK4.
    Lou X; Meng Y; Hou Y
    J Cell Mol Med; 2021 Mar; 25(6):2786-2794. PubMed ID: 33586359
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells.
    Jingyue S; Xiao W; Juanmin Z; Wei L; Daoming L; Hong X
    Mol Med Rep; 2019 Jul; 20(1):323-331. PubMed ID: 31115533
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Future paradigms for precision oncology.
    Klement GL; Arkun K; Valik D; Roffidal T; Hashemi A; Klement C; Carmassi P; Rietman E; Slaby O; Mazanek P; Mudry P; Kovacs G; Kiss C; Norga K; Konstantinov D; André N; Slavc I; van Den Berg H; Kolenova A; Kren L; Tuma J; Skotakova J; Sterba J
    Oncotarget; 2016 Jul; 7(29):46813-46831. PubMed ID: 27223079
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transcriptomic changes associated with DKK4 overexpression in pancreatic cancer cells detected by RNA-Seq.
    Ouyang Y; Pan J; Tai Q; Ju J; Wang H
    Tumour Biol; 2016 Aug; 37(8):10827-38. PubMed ID: 26880586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Takahashi T; Yamahsita S; Matsuda Y; Kishino T; Nakajima T; Kushima R; Kato K; Igaki H; Tachimori Y; Osugi H; Nagino M; Ushijima T
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):453-63. PubMed ID: 25273507
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Collagen as a double-edged sword in tumor progression.
    Fang M; Yuan J; Peng C; Li Y
    Tumour Biol; 2014 Apr; 35(4):2871-82. PubMed ID: 24338768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TFAP2E-DKK4 and chemoresistance in colorectal cancer.
    Giovannetti E; Codacci-Pisanelli G; Peters GJ
    N Engl J Med; 2012 Mar; 366(10):966; author reply 966. PubMed ID: 22397669
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.